Alerts will be sent to your verified email
Verify Email
AAREYDRUGS
|
Aarey Drugs & Pharma
|
Syschem (India)
|
Lyka Labs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
4.4 % | -15.43 % | 62.44 % |
|
5yr average Equity Multiplier
|
2.28 | 5.54 | 2.9 |
|
5yr Average Asset Turnover Ratio
|
1.58 | 1.2 | 0.73 |
|
5yr Avg Net Profit Margin
|
1.23 % | -1.1 % | -0.79 % |
|
Price to Book
|
1.47 | 2.22 | 2.22 |
|
P/E
|
63.6 | 25.78 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
60.21 Days | 2.82 Days | 32.55 Days |
|
Inventory Days
|
21.8 Days | 86.99 Days | 24.2 Days |
|
Days Receivable
|
122.43 Days | 74.65 Days | 92.33 Days |
|
Days Payable
|
103.05 Days | 168.44 Days | 106.74 Days |
|
5yr Average Interest Coverage Ratio
|
3.59 | 8.6 | 2.2 |
|
5yr Avg ROCE
|
8.53 % | -1.51 % | 25.83 % |
|
5yr Avg Operating Profit Margin
|
1.54 % | 1.15 % | 24.02 % |
|
5 yr average Debt to Equity
|
0.22 | 0.49 | 1.25 |
|
5yr CAGR Net Profit
|
-9.19 % | n/a | n/a |
|
5yr Average Return on Assets
|
1.94 % | -0.74 % | 1.72 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
39.06 % | 56.71 % | 58.16 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-10.97 % | 2.89 % | 10.57 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | -3.53 % |
|
Aarey Drugs & Pharma
|
Syschem (India)
|
Lyka Labs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|